Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc. (GRDN) Stock Overview
Explore Guardian Pharmacy Services, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.3B
P/E Ratio
-15.94
EPS (TTM)
$-1.59
ROE
-0.74%
GRDN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Guardian Pharmacy Services, Inc. (GRDN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $35.85.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.94 and a market capitalization of 1.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Fred P. Burke
3,400
300 Galleria Parkway SE, Atlanta, GA
2016